US pharma major Eli Lilly (NYSE: LLY) has provided an update on compounding litigation relating to tirzepatide, its drug for type 2 diabetes and weight loss tha 16 May 2024
Shares in Merck KGaA rose by around 4% in Wednesday’s trading after the Germany-based company presented its first quarter financial results and latest forecast 15 May 2024
Four-year data from the SELECT trial will significantly bolster Novo Nordisk’s (NOVO: N) bid to become the GLP-1 company of choice for payers and prescribers. 15 May 2024
French pharma major Sanofi has announced an investment of more than 1 billion euros ($1.08 billion) to create new bioproduction capacity at its sites in Vitry-s 14 May 2024
US pharma giant Merck & Co raised and narrowed its forecasts for profit and sales for 2024 in presenting its first-quarter financial results. 25 April 2024
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.